Safety of intravenous gadolinium (Gd-BOPTA) infusion in patients with renal insufficiency
- 1 December 2000
- journal article
- clinical trial
- Published by Elsevier BV in American Journal of Kidney Diseases
- Vol. 36 (6), 1207-1212
- https://doi.org/10.1053/ajkd.2000.19836
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Gadobenate Dimeglumine (Gd-BOPTA)Investigative Radiology, 1998
- Use of gadopentetate dimeglumine as a contrast agent for percutaneous transluminal renal angioplasty and stent placementKidney International, 1998
- Contrast-medium-induced acute renal failureKidney International, 1998
- Gadolinium Chelates with Weak Binding to Serum ProteinsInvestigative Radiology, 1997
- Nephrotoxicity of high‐dose gadolinium compared with iodinated contrastJournal of Magnetic Resonance Imaging, 1996
- Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trialKidney International, 1995
- Renal Tolerance of Gadolinium-DTPA/Dimeglumine in Patients with Chronic Renal FailureInvestigative Radiology, 1992
- Safety of gadolinium‐DTPA: Extended clinical experienceMagnetic Resonance in Medicine, 1991
- Pharmacokinetics of Gd-DTPA in Patients with Chronic Renal FailureInvestigative Radiology, 1991
- Measurement of renal function in chronic renal diseaseKidney International, 1990